Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 3,682Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 3Orion Corporation

02 3Actavis Group PTC ehf

03 1Adamed Sp. z.o.o.

04 3Avansor Pharma Oy

05 1Central Procurement & Supplies Unit

06 6Cheplapharm Registration Gmbh

07 3Cheplapharm Schweiz Gmbh

08 2Cherubino Limited

09 3Glenmark Arzneimittel Gmbh

10 3Krka Dd, Novo Mesto

11 3Medical Valley Invest Ab

12 3Mylan Ab

13 3Nobel Ilac Sanayii Ve Ticaret A.S.

14 1Orifarm AS

15 2Pharma MT

16 2Pharmascience International Ltd

17 2ROCHE REGISTRATION LTD

18 3Ratiopharm Gmbh

19 3Roche Registration Ltd

20 3Sandoz A/S

21 3Stada Pharmaceuticals Ag

22 3Teva Bv

23 3Teva Sweden Ab

24 2UQUIFA

25 3Zentiva Ks

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

Erlotinibhydroklorid

Brand Name : Erlotinib Orion

Dosage Form : Film Coated Tablet

Dosage Strength : 100mg

Packaging :

Approval Date : 15/01/2019

Application Number : 20171220000027

Regulatory Info : Deregistered

Registration Country : Sweden

Fermion Orion Company Banner

02

Erlotinibhydroklorid

Brand Name : Erlotinib Orion

Dosage Form : Film Coated Tablet

Dosage Strength : 150mg

Packaging :

Approval Date : 15/01/2019

Application Number : 20171220000034

Regulatory Info : Deregistered

Registration Country : Sweden

Fermion Orion Company Banner

03

Erlotinibhydroklorid

Brand Name : Erlotinib Orion

Dosage Form : Film Coated Tablet

Dosage Strength : 25mg

Packaging :

Approval Date : 15/01/2019

Application Number : 20171220000010

Regulatory Info : Deregistered

Registration Country : Sweden

Fermion Orion Company Banner

04

ISPOR Europe 2025
Not Confirmed
arrow
arrow
ISPOR Europe 2025
Not Confirmed

Erlotinib

Brand Name :

Dosage Form :

Dosage Strength :

Packaging :

Approval Date :

Application Number :

Regulatory Info : Generic

Registration Country : Poland

blank

05

ISPOR Europe 2025
Not Confirmed
arrow
arrow
ISPOR Europe 2025
Not Confirmed

Erlotinib

Brand Name : Tarceva

Dosage Form : Erlotinib 100Mg 30 Joined' Oral Use

Dosage Strength : 30 cpr riv 100 mg

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

blank

06

ISPOR Europe 2025
Not Confirmed
arrow
arrow
ISPOR Europe 2025
Not Confirmed

Erlotinib

Brand Name : Tarceva

Dosage Form : Erlotinib 150Mg 30 Joined' Oral Use

Dosage Strength : 30 cpr riv 150 mg

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

blank

07

ISPOR Europe 2025
Not Confirmed
arrow
arrow
ISPOR Europe 2025
Not Confirmed

Erlotinib

Brand Name : Tarceva

Dosage Form : Antic-calc Tablet, Film Coated

Dosage Strength : 100 mg

Packaging : Blister

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

blank

08

ISPOR Europe 2025
Not Confirmed
arrow
arrow
ISPOR Europe 2025
Not Confirmed

Erlotinib

Brand Name : Ertinob

Dosage Form : Film Coated Tablet

Dosage Strength : 25MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Turkey

blank

09

ISPOR Europe 2025
Not Confirmed
arrow
arrow
ISPOR Europe 2025
Not Confirmed

Erlotinib

Brand Name : Ertinob

Dosage Form : Film Coated Tablet

Dosage Strength : 100MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Turkey

blank

10

ISPOR Europe 2025
Not Confirmed
arrow
arrow
ISPOR Europe 2025
Not Confirmed

Erlotinib

Brand Name : Ertinob

Dosage Form : Film Coated Tablet

Dosage Strength : 150MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Turkey

blank